May 19, 2020 | In the Media, News
The HIV Prevention Trials Network (HPTN) announced results from HPTN 083, a global randomized, controlled, double-blind study that compared the safety and efficacy of long-acting injectable cabotegravir (CAB LA) to daily oral tenofovir/emtricitabine (TDF/FTC)...
Dec 22, 2019 | Stories from the Field
Across the world, the introduction of antiretroviral therapy (ART) and the progress made to HIV service delivery transformed a once-deadly disease into a chronic, manageable condition—presenting a hopeful future where people living with HIV could live long, healthy,...